
ABS or access to genetic resources and benefit sharing arising out of their utilization is one of the three objectives of the Convention on Biological Diversity. The idea behind it is that the pharmaceutical, cosmetic and food industry make profits that are partially based on the biodiversity and local knowledge in tropical countries – and that we neeed an international regime to make sure that part of these profits go to the communities that provided knowledge on and or access to the genetic resources. The CBD would like to define key audiences and messages. But I would say that at the moment you can’t say more than "we are developing an international regime for the 'fair trade' in genetic resources" and for the rest stick to two-way communication approaches (click on the matrix from the CEPA toolkit).
No comments:
Post a Comment